Advantage $EBS vs. $JNJ, $NVAX, $VXRT, $AZN:

Inventors, US Gov &amp; NGOs cover the CoV19-related capacity expansion. 

Some/one inventor(s) succeed(s), other fail.

$EBS will be able to use all funded production capacity for the CoV(s), which succeeded.